Nanoparticle-Delivered 2-PAM for Rat Brain Protection against Paraoxon Central Toxicity

ACS Applied Materials & Interfaces
Tatiana N PashirovaOleg G Sinyashin

Abstract

Solid lipid nanoparticles (SLNs) are among the most promising nanocarriers to target the blood-brain barrier (BBB) for drug delivery to the central nervous system (CNS). Encapsulation of the acetylcholinesterase reactivator, pralidoxime chloride (2-PAM), in SLNs appears to be a suitable strategy for protection against poisoning by organophosphorus agents (OPs) and postexposure treatment. 2-PAM-loaded SLNs were developed for brain targeting and delivery via intravenous (iv) administration. 2-PAM-SLNs displayed a high 2-PAM encapsulation efficiency (∼90%) and loading capacity (maximum 30.8 ± 1%). Drug-loaded particles had a mean hydrodynamic diameter close to 100 nm and high negative zeta potential (-54 to -15 mV). These properties contribute to improve long-term stability of 2-PAM-SLNs when stored both at room temperature (22 °C) and at 4 °C, as well as to longer circulation time in the bloodstream compared to free 2-PAM. Paraoxon-poisoned rats (2 × LD50) were treated with 2-PAM-loaded SLNs at a dose of 2-PAM of 5 mg/kg. 2-PAM-SLNs reactivated 15% of brain AChE activity. Our results confirm the potential use of SLNs loaded with positively charged oximes as a medical countermeasure both for protection against OPs poisoning and fo...Continue Reading

References

Jul 1, 1961·Biochemical Pharmacology·G L ELLMANR M FEATHER-STONE
Apr 28, 2004·Advanced Drug Delivery Reviews·S A WissingR H Müller
May 4, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Carsten OlbrichRainer H Müller
Jul 6, 2005·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Torsten M Göppert, Rainer H Müller
Jan 1, 1948·American Journal of Public Health and the Nation's Health·E S WEISS
Mar 11, 2010·Journal of Microencapsulation·Jürgen KufleitnerJörg Kreuter
May 13, 2010·Chemical & Pharmaceutical Bulletin·Sanjay SinghSubhashis Chakraborty
May 26, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Pascal HouzéFrédéric J Baud
Aug 24, 2010·International Journal of Pharmaceutics·R ShegokarR H Müller
Dec 15, 2010·PloS One·Sylvia WagnerHagen von Briesen
Jun 30, 2011·Pharmaceutical Development and Technology·J F FangueiroE B Souto
Mar 1, 2012·Accounts of Chemical Research·Guillaume MerceyPierre-Yves Renard
Dec 12, 2012·International Journal of Pharmaceutics·Rohit Bhandari, Indu Pal Kaur
Apr 5, 2013·Expert Opinion on Drug Delivery·Medha PatelKamalinder K Singh
Jul 9, 2013·International Journal of Pharmaceutics·Paolo BlasiMaurizio Ricci
Jul 31, 2013·Journal of Biomedical Materials Research. Part a·Ehsan AboutalebRassoul Dinarvand
Nov 19, 2013·Journal of Applied Toxicology : JAT·Slavomira DoktorovovaPaula Martins-Lopes
Feb 18, 2014·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Slavomira DoktorovovaAmélia M Silva
May 6, 2014·International Journal of Pharmaceutics·Antonio LeonardiRosario Pignatello
May 14, 2014·European Journal of Medicinal Chemistry·Patrícia SeverinoEliana B Souto
May 17, 2014·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Lucia GastaldiFranco Dosio
Jul 6, 2014·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Miriam DadparvarJörg Kreuter
Aug 26, 2014·Expert Opinion on Drug Delivery·Mona H Aburahma, Shaimaa M Badr-Eldin
Sep 2, 2014·International Journal of Pharmaceutics·Joana F FangueiroAna C Calpena
Oct 8, 2014·Journal of Applied Toxicology : JAT·H KalászK Tekes
Oct 12, 2014·Colloids and Surfaces. B, Biointerfaces·Joana F FangueiroEliana B Souto
Dec 3, 2014·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Patrícia SeverinoEliana B Souto
Jun 19, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·João AlbuquerqueSalette Reis
Jun 27, 2015·ACS Nano·Samir MitragotriChenjie Xu
Sep 15, 2015·British Journal of Clinical Pharmacology·Michael Eddleston, Fazle Rabbi Chowdhury
Sep 28, 2015·Nanomedicine : Nanotechnology, Biology, and Medicine·Ana BeloquiVéronique Préat
Dec 10, 2015·Biomaterials Science·Tian-Tian ZhangWenzhen Liao
Jan 3, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Lindsey CrawfordDavid Putnam
Apr 14, 2016·Expert Opinion on Drug Delivery·Ivana CacciatoreAntonio Di Stefano
May 22, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Cláudia SaraivaLiliana Bernardino
Jun 12, 2016·Chemico-biological Interactions·Marloes J A JoosenRoland M van den Berg
Jul 9, 2016·Biomaterials·Juan Aparicio-BlancoAna-Isabel Torres-Suárez

❮ Previous
Next ❯

Citations

Oct 13, 2017·Nanomaterials·Sérgio M F VilelaPatricia Horcajada
Feb 12, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Raquel VieiraEliana B Souto
Mar 30, 2018·Frontiers in Pharmacology·Sofya V LushchekinaPatrick Masson
Nov 14, 2020·Critical Reviews in Toxicology·Maria Alozi, Mutasem Rawas-Qalaji
Oct 24, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yadan ZhangDongqin Quan
Mar 3, 2021·Nature Reviews. Drug Discovery·Georg C TerstappenWandong Zhang
Jul 1, 2020·ACS Applied Materials & Interfaces·Pamela T WongSeok Ki Choi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.